HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment.

AuthorsHélène Monjanel, Christophe Hourioux, Flavie Arbion, Philippe Colombat, Séverine Lissandre, Marie Paule Regner, Delphine Senecal
JournalLeukemia research (Leuk Res) Vol. 34 Issue 8 Pg. e197-9 (Aug 2010) ISSN: 1873-5835 [Electronic] England
PMID20211489 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab
Topics
  • Alemtuzumab
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Drug Resistance, Neoplasm
  • Humans
  • Leukemia, Large Granular Lymphocytic (drug therapy, genetics)
  • Male
  • Middle Aged
  • Remission Induction
  • Salvage Therapy
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: